Page last updated: 2024-12-07

melarsomine dihydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123720
CHEMBL ID3215666
SCHEMBL ID526148
MeSH IDM0473938

Synonyms (34)

Synonym
melcy
melaminylthioarsenite
arsonodithious acid, (4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)-, bis(2-aminoethyl) ester, dihydrochloride
melaminylthioarsenate
rm-110
cymelarsan
cymelarsen
rm 110
mel cy
melarsomine dihydrochloride
immiticide
9cva716q71 ,
arsonodithious acid, as-(4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)-, bis(2-aminoethyl) ester, hydrochloride (1:2)
bis(2-aminoethyl) p-((4,6-diamino-s-triazin-2-yl)amino)dithiobenzenearsonite dihydrochloride
89141-50-4
n2-(4-(bis(2-aminoethylsulfanyl)arsanyl)phenyl)-1,3,5-triazine-2,4,6-triamine dihydrochloride
unii-9cva716q71
rm110
melarsomine dihydrochloride [green book]
melarsomine dihydrochloride [mi]
SCHEMBL526148
CHEMBL3215666
melarsenoxide cysteamine
DTXSID90237545 ,
2-n-[4-[bis(2-aminoethylsulfanyl)arsanyl]phenyl]-1,3,5-triazine-2,4,6-triamine;dihydrochloride
Q27272369
CS-0148514
HY-138502A
melarsomine (dihydrochloride)
immiticide sterile powder
melarsomine dihydrochloride and water
diroban
dtxcid40160036
AKOS040758436

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" It therefore appears that drug bioavailability is altered or drug biotransformation occurs during the in vivo test."( In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
Baltz, T; Giroud, C; Zhang, ZQ, 1991
)
0.28

Dosage Studied

ExcerptRelevanceReference
" The activity of each drug was expressed as: 1) in vitro: the minimal effective concentration which killed trypanosome population by 100% within 24 h of drug exposure (MEC100); the maximum tolerated concentration in which trypanosomes could propagate at the same rate as the controls during 48 h of drug exposure (MTC100); 2) in vivo: the curative dosage in 100% of infected mice (CD100); the highest ineffective dosage: 100% of infected mice remain infected (ID100)."( In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
Baltz, T; Giroud, C; Zhang, ZQ, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID660875Antitrypanosomal activity against TbAt1-deficient bloodstraem form Trypanosoma brucei brucei B48 after 72 hrs by alamar blue assay2011ACS medicinal chemistry letters, Dec-08, Volume: 2, Issue:12
Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activity.
AID660874Antitrypanosomal activity against TbAt1-deficient bloodstraem form of Trypanosoma brucei brucei 427 (BS221) after 72 hrs by alamar blue assay2011ACS medicinal chemistry letters, Dec-08, Volume: 2, Issue:12
Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activity.
AID1394878Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as change in mean survival time at 100 mg/kg, ip administered as single dose measured up to 30 days2018European journal of medicinal chemistry, Apr-25, Volume: 150Synthesis and antikinetoplastid evaluation of bis(benzyl)spermidine derivatives.
AID660873Antitrypanosomal activity against bloodstream form of Trypanosoma brucei brucei 427 (BS221) after 72 hrs by alamar blue assay2011ACS medicinal chemistry letters, Dec-08, Volume: 2, Issue:12
Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activity.
AID1394880Toxicity in Swiss mouse assessed as death at 100 mg/kg, ip administered as single dose measured up to 30 days2018European journal of medicinal chemistry, Apr-25, Volume: 150Synthesis and antikinetoplastid evaluation of bis(benzyl)spermidine derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.00)18.7374
1990's32 (64.00)18.2507
2000's7 (14.00)29.6817
2010's10 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.80 (24.57)
Research Supply Index4.04 (2.92)
Research Growth Index6.30 (4.65)
Search Engine Demand Index57.60 (26.88)
Search Engine Supply Index3.29 (0.95)

This Compound (30.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (5.66%)5.53%
Reviews2 (3.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (90.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]